The vascular grafts market is expected to reach USD 3.80 Billion by 2022 from USD 2.67 Billion in 2017, at a CAGR of 7.3%. Factors driving the growth of this market includein the aging population and the associated increase in the prevalence of aneurysms, rise in end-stage renal disorders, and increasing adoption of minimally invasive surgical procedures.
By raw material, the vascular grafts market is segmented into ePTFE grafts, polyester grafts, polyurethane grafts, and biosynthetic grafts. Polyester grafts are likely to dominate this market in 2017. The growth of this segment is primarily driven by various factors such as high demand for polyester material based grafts owing to its various benefits such as a long lifespan and high patency and porousness.
North America is estimated to command the largest share of the market
Based on region, the vascular grafts market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is expected to dominate this market in 2017. Factors such as increasing healthcare expenditure and research and development in the field of vascular grafts are propelling the growth of the vascular grafts market in this region.
Key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).
Comments
Post a Comment